205 related articles for article (PubMed ID: 23824785)
41. Buflomedil for intermittent claudication.
de Backer TL; Vander Stichele R
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD000988. PubMed ID: 23543509
[TBL] [Abstract][Full Text] [Related]
42. Ginkgo biloba for intermittent claudication.
Nicolaï SP; Kruidenier LM; Bendermacher BL; Prins MH; Stokmans RA; Broos PP; Teijink JA
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD006888. PubMed ID: 23744597
[TBL] [Abstract][Full Text] [Related]
43. Naftidrofuryl for intermittent claudication.
De Backer TL; Vander Stichele R; Lehert P; Van Bortel L
Cochrane Database Syst Rev; 2008 Apr; (2):CD001368. PubMed ID: 18425872
[TBL] [Abstract][Full Text] [Related]
44. Buflomedil for intermittent claudication.
de Backer TL; Bogaert M; Vander Stichele R
Cochrane Database Syst Rev; 2008 Jan; (1):CD000988. PubMed ID: 18253982
[TBL] [Abstract][Full Text] [Related]
45. Omega-3 fatty acids plus vitamin for women with gestational diabetes or prediabetes: a meta-analysis of randomized controlled studies.
Jiang L; Gao C; Yan P; Chen P; Jiang C; Xu Y; Chen M
J Matern Fetal Neonatal Med; 2022 Aug; 35(16):3135-3142. PubMed ID: 32967476
[TBL] [Abstract][Full Text] [Related]
46. Treatment of hypertension in peripheral arterial disease.
Lane DA; Lip GY
Cochrane Database Syst Rev; 2009 Oct; (4):CD003075. PubMed ID: 19821300
[TBL] [Abstract][Full Text] [Related]
47. Lipid-lowering for peripheral arterial disease of the lower limb.
Aung PP; Maxwell HG; Jepson RG; Price JF; Leng GC
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD000123. PubMed ID: 17943736
[TBL] [Abstract][Full Text] [Related]
48. Beta blockers for peripheral arterial disease.
Paravastu SC; Mendonca D; Da Silva A
Cochrane Database Syst Rev; 2008 Oct; (4):CD005508. PubMed ID: 18843692
[TBL] [Abstract][Full Text] [Related]
49. Omega 3 fatty acids for prevention and treatment of cardiovascular disease.
Hooper L; Thompson RL; Harrison RA; Summerbell CD; Moore H; Worthington HV; Durrington PN; Ness AR; Capps NE; Davey Smith G; Riemersma RA; Ebrahim SB
Cochrane Database Syst Rev; 2004 Oct; (4):CD003177. PubMed ID: 15495044
[TBL] [Abstract][Full Text] [Related]
50. Endovascular stents for intermittent claudication.
Bachoo P; Thorpe PA; Maxwell H; Welch K
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD003228. PubMed ID: 20091540
[TBL] [Abstract][Full Text] [Related]
51. Screening for peripheral arterial disease.
Andras A; Ferket B
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010835. PubMed ID: 24711093
[TBL] [Abstract][Full Text] [Related]
52. Steroid sex hormones for lower limb atherosclerosis.
Price J; Leng GC
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD000188. PubMed ID: 23076884
[TBL] [Abstract][Full Text] [Related]
53. Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.
Andras A; Stansby G; Hansrani M
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD003285. PubMed ID: 23881650
[TBL] [Abstract][Full Text] [Related]
54. The effects of dietary intervention on HIV dyslipidaemia: a systematic review and meta-analysis.
Stradling C; Chen YF; Russell T; Connock M; Thomas GN; Taheri S
PLoS One; 2012; 7(6):e38121. PubMed ID: 22701607
[TBL] [Abstract][Full Text] [Related]
55. Intravenous naftidrofuryl for critical limb ischaemia.
Smith FB; Bradbury A; Fowkes G
Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD002070. PubMed ID: 22786478
[TBL] [Abstract][Full Text] [Related]
56. Garlic for peripheral arterial occlusive disease.
Jepson RG; Kleijnen J; Leng GC
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD000095. PubMed ID: 23633303
[TBL] [Abstract][Full Text] [Related]
57. The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis.
Enns JE; Yeganeh A; Zarychanski R; Abou-Setta AM; Friesen C; Zahradka P; Taylor CG
BMC Cardiovasc Disord; 2014 May; 14():70. PubMed ID: 24885361
[TBL] [Abstract][Full Text] [Related]
58. Omega-3 Polyunsaturated Fatty Acid Supplementation in Patients with Lower Extremity Arterial Disease.
Su MI; Cheng YC; Huang YC; Liu CW
J Am Nutr Assoc; 2022; 41(4):383-391. PubMed ID: 33750272
[TBL] [Abstract][Full Text] [Related]
59. Omega-3 fatty acids supplementation on major cardiovascular outcomes: an umbrella review of meta-analyses of observational studies and randomized controlled trials.
Choi H; Kim JY; Lee KH; Kim JS; Lee JY; Choi EK; Seong HJ; Kim G; Park H; Jung E; Hong SH; Kronbichler A; Eisenhut M; Koyanagi A; Jacob L; Yon DK; Lee SW; Kim MS; Kostev K; Shin JI; Yang JW; Smith L
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):2079-2092. PubMed ID: 33660821
[TBL] [Abstract][Full Text] [Related]
60. The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials.
Chewcharat A; Chewcharat P; Rutirapong A; Papatheodorou S
PLoS One; 2020; 15(2):e0228315. PubMed ID: 32045421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
